Next Article in Journal
Exploring Variability in Rifampicin Plasma Exposure and Development of Anti-Tuberculosis Drug-Induced Liver Injury among Patients with Pulmonary Tuberculosis from the Pharmacogenetic Perspective
Previous Article in Journal
Mesoporous Silica as an Alternative Vehicle to Overcome Solubility Limitations
Previous Article in Special Issue
The Development of an Oral Solution Containing Nirmatrelvir and Ritonavir and Assessment of Its Pharmacokinetics and Stability
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(3), 387; https://doi.org/10.3390/pharmaceutics16030387
Action Date Notes Link
article xml file uploaded 12 March 2024 09:14 CET Original file -
article xml uploaded. 12 March 2024 09:14 CET Update https://www.mdpi.com/1999-4923/16/3/387/xml
article pdf uploaded. 12 March 2024 09:14 CET Version of Record https://www.mdpi.com/1999-4923/16/3/387/pdf
article supplementary file uploaded. 12 March 2024 09:14 CET - https://www.mdpi.com/1999-4923/16/3/387#supplementary
article html file updated 12 March 2024 09:16 CET Original file https://www.mdpi.com/1999-4923/16/3/387/html
Back to TopTop